METHOD OF COMPLEX STAGE-BY-STAGE TREATMENT OF POSTERIOR BLEPHARITIS COMBINED WITH DEMODECTIC LESION OF EYELIDS Russian patent published in 2018 - IPC A61F7/02 A61F9/00 A61K31/4164 A61K31/495 A61K31/573 A61K31/7036 A61K31/726 A61K33/22 A61P27/02 A61P33/14 A61B3/135 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used to treat posterior blepharitis associated with demodectic lesions of the eyelids. For this purpose, for 10 days, 2 times a day, Dexa-gentamicin ointment is applied to the edges of the eyelids. Further, from the 11th day of treatment, the therapeutic hygiene of the eyelids is carried out. To do this, clean the edges of the eyelids with Teagel 2 times a day for 45 days and apply 3-4 hot compresses of gauze napkins for 2–3 minutes each after closed eyelids, after which the eyelid massage under the slit lamp is performed. Procedure of massage is completed by treating the conjunctival cavity and the edge of the eyelids with Vitabakt antiseptic. Wherein, hot compresses and eyelid massage are carried out once a week for 3 weeks. Further, starting from the 32nd day of treatment, antiparasitic therapy is performed: under the instillation anesthesia, the metronidazole-containing preparation Glikodem is applied to the edges of the eyelids, then the drug is pushed into each meibomian gland by a micro-spatula under the slit lamp. Antiparasitic therapy is performed once a day for 45 days. Moreover, starting from the first day of treatment, the patient is instilled with tear-suppressing drugs 4 times a day for 6 months.

EFFECT: method ensures the normalization of the function of meibomian glands due to the release of their lumen from the inflammatory secretion, the improvement of lipid production by meibomian glands, as well as a reduction in the inter-recessive period of demodexia lesions due to the direct effect of the antiparasitic drug on the causative agent of the disease.

1 cl, 2 ex